INFU | Market Cap: $187.7M (07/13/26)
Industry:
Healthcare Equipment, Supplies, & Technology

DESCRIPTION

InfuSystem is a national healthcare services company that rents ambulatory infusion pumps to oncology clinics and other outpatient settings. The core business involves delivering portable pumps to cancer patients — primarily colorectal cancer patients — for continuous chemotherapy administration at home. InfuSystem acts as an intermediary between oncology clinics, patients, and insurers: it delivers the pump, handles all billing and insurance claims, provides 24/7 nursing support, and manages pump maintenance. Oncologists outsource the capital, administrative, and billing burdens of pump ownership to InfuSystem while keeping the patient relationship. InfuSystem serves approximately 2,100 outpatient oncology clinics across the U.S. and Canada and contracts with nearly 840 payer networks. The company operates two segments: Patient Services (the larger segment, centered on oncology) and Device Solutions (a more transactional business renting and selling pumps to hospitals and clinics, and providing biomedical maintenance services). Beyond its core oncology business, InfuSystem is expanding into wound care (negative pressure wound therapy, advanced wound dressings, and pneumatic compression devices) and pain management (post-surgical nerve block pumps), leveraging its existing payer contracts and billing infrastructure. InfuSystem targets low to mid-single-digit annual growth in oncology, with wound care as the main near-term growth driver. The company also pursues small, regional DME acquisitions that lack its scale of payer contracts and logistics infrastructure.

Read full business overview →